Epidemiology

  1. Patients with benign breast disease and breast cancer need more COVID-19 vaccines

    1. Huai-liang Wu
    2. Zong-lin He
    3. Yue Gong
    4. Miao Mo
    5. Guang-yu Liu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Effectiveness of BNT162b2 against COVID-19 in adolescents

    1. Annabel A Powell
    2. Freja Kirsebom
    3. Julia Stowe
    4. Kelsey McOwat
    5. Vanessa Saliba
    6. Mary E Ramsay
    7. Jamie Lopez-Bernal
    8. Nick Andrews
    9. Shamez N Ladhani

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia

    1. Luděk Berec
    2. Martin Šmíd
    3. Lenka Přibylová
    4. Ondřej Májek
    5. Tomáš Pavlík
    6. Jiří Jarkovský
    7. Milan Zajíček
    8. Jakub Weiner
    9. Tamara Barusová
    10. Jan Trnka

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021–July 2021

    1. Megha L Mehrotra
    2. Esther Lim
    3. Katherine Lamba
    4. Amanda Kamali
    5. Kristina W Lai
    6. Erika Meza
    7. Irvin Szeto
    8. Peter Robinson
    9. Cheng-ting Tsai
    10. David Gebhart
    11. Noemi Fonseca
    12. Andrew B Martin
    13. Catherine Ley
    14. Steve Scherf
    15. James Watt
    16. David Seftel
    17. Julie Parsonnet
    18. Seema Jain

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021

    1. Alison Levin-Rector
    2. Lauren Firestein
    3. Emily McGibbon
    4. Jessica Sell
    5. Sungwoo Lim
    6. Ellen H Lee
    7. Don Weiss
    8. Anita Geevarughese
    9. Jane R Zucker
    10. Sharon K Greene

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England

    1. Shamez N. Ladhani
    2. Georgina Ireland
    3. Frances Baawuah
    4. Joanne Beckmann
    5. Ifeanyichukwu O. Okike
    6. Shazaad Ahmad
    7. Joanna Garstang
    8. Andrew J. Brent
    9. Bernadette Brent
    10. Felicity Aiano
    11. Zahin Amin-Chowdhury
    12. Meaghan Kall
    13. Ray Borrow
    14. Ezra Linley
    15. Maria Zambon
    16. John Poh
    17. Lenesha Warrener
    18. Angie Lackenby
    19. Joanna Ellis
    20. Gayatri Amirthalingam
    21. Kevin E. Brown
    22. Mary E. Ramsay

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Exploring selection bias in COVID-19 research: Simulations and prospective analyses of two UK cohort studies

    1. Louise AC Millard
    2. Alba Fernández-Sanlés
    3. Alice R Carter
    4. Rachael Hughes
    5. Kate Tilling
    6. Tim P Morris
    7. Daniel Major-Smith
    8. Gareth J Griffith
    9. Gemma L Clayton
    10. Emily Kawabata
    11. George Davey Smith
    12. Deborah A Lawlor
    13. Maria Carolina Borges

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion

    1. Frederic Grabowski
    2. Marek Kochańczyk
    3. Tomasz Lipniacki

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study

    1. Daniel Ayoubkhani
    2. Charlotte Bermingham
    3. Koen B Pouwels
    4. Myer Glickman
    5. Vahé Nafilyan
    6. Francesco Zaccardi
    7. Kamlesh Khunti
    8. Nisreen A Alwan
    9. A Sarah Walker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Population Optimally Immunized after Accounting for Type-Specific COVID-19 Vaccine Waning Intervals: State-Level Prevalence and Trends

    1. Elizabeth B. Pathak
    2. Jason L. Salemi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 142 of 465 Next